Low dose estradiol gender-affirming hormone therapy (GAHT) generates rapid feminizing body changes in transgender women: a dual energy x-ray absorptiometry-based prospective study | Synapse
May 6, 2024
Low dose estradiol gender-affirming hormone therapy (GAHT) generates rapid feminizing body changes in transgender women: a dual energy x-ray absorptiometry-based prospective study
Key Points
Key points are not available for this paper at this time.
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)